When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set of voices: doctors and pharmacists with deep financial ties to the burgeoning industry of unproven chemicals.
The Food and Drug Administration on Monday released its list of participants for an upcoming meeting to reconsider the safety and effectiveness of several popular peptide injections, including some that have been praised by Health Secretary Robert F. Kennedy Jr.